Nyxoah logo
Nyxoah
NYXH | NASDAQ
Chart Builder DCF Calculator
$0.89
-$0.01 (-1.06%)
At close: Nov 16, 2026, 4:00 PM ET
$0.89
$0.00 (+0.42%)
After-hours: Nov 16, 2026, 7:30 PM ET

Nyxoah Company Profile

Company profile explained

Company Profile

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Key Executives

Name Position
Liam J. Kelly Chief Executive Officer
Olivier Taelman Chief Executive Officer
John Landry Chief Financial Officer
An Moonen General Counsel
Ashlea Mittelstaedt Chief Strategy Officer
Bruno Onkelinx Chief Technical Officer
Geeta Kaveti Chief Compliance Officer
Jeyakumar Subbaroyan Chief Science Officer
Loic Moreau President of International & Interim CFO
Maurits S. Boon Chief Medical Officer
Pearson Dennis Investor Relations Associate
Remi Renard Head of Investor Relations & Corporate Communication
Robert Taub Co-Founder & Chairman
Scott Holstine Chief Commercial Officer

Latest SEC Filings

Date Type Title
Oct 20, 2026 6-K Filing
Sep 29, 2026 6-K Filing
Sep 22, 2026 6-K Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 05, 2026 6-K Filing
Jul 09, 2026 6-K Filing
Jul 01, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Jun 23, 2026 6-K Filing
Jun 22, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Jun 11, 2026 6-K Filing
View All SEC Filings ➞
Nyxoah
Nyxoah logo
Country Belgium
IPO Date Apr 28, 2021
Industry Medical - Specialties
Sector Healthcare
Employees 154
CEO Liam J. Kelly

Contact Details

Rue Edouard Belin 12 Mont-Saint-Guibert, Washington 1435 Belgium

Stock Details

Ticker Symbol NYXH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001857190
CUSIP Number n/a
ISIN Number BE0974358906
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.